Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Summary
Directly examine whether early (6-month) imaging with DaTscan and \[¹⁸F\] AV-133 will provide an early signal of disease progression in recently diagnosed untreated PD patients.
Official title: Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™ (PPMI Early Imaging)
Key Details
Gender
All
Age Range
30 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2020-09-10
Completion Date
2025-06
Last Updated
2024-10-31
Healthy Volunteers
No
Conditions
Locations (3)
Institute For Neurodegenerative Disorders
New Haven, Connecticut, United States
Boston University Medical Center
Boston, Massachusetts, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States